Skip to main content
Log in

Prostate cancer

Benefit and safety of adjuvant radiation therapy

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

10-year data from the European Organisation for Research and Treatment of Cancer trial 22911 have been published, reigniting the debate regarding postoperative radiotherapy for prostate cancer. These data show that adjuvant radiotherapy significantly improves biochemical progression-free survival and local control compared with a 'wait-and-see' policy, supporting the 5-year follow-up data.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bolla, M. et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 366, 572–578 (2005).

    Article  Google Scholar 

  2. van der Kwast, T. et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J. Clin. Oncol. 25, 4178–4186 (2007).

    Article  Google Scholar 

  3. Thompson, I. M. et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized trial. JAMA 296, 2329–2335 (2006).

    Article  CAS  Google Scholar 

  4. Wiegel, T. et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate specific antigen: ARO 96–02/AUO AP 09/95. J. Clin. Oncol. 27, 2924–2930 (2009).

    Article  Google Scholar 

  5. Trabulsi, E. J. et al. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3–4N03. Urology 72, 1298–1304 (2008).

    Article  Google Scholar 

  6. Ghadjar, P., Zwahlen, D., Aebersold, D. M. & Zimmermann, F. Postoperative radiotherapy after radical prostatectomy: indications and open questions. Prostate Cancer http://dx.doi.org/10.1155/2012/963417.

  7. Detti, B. et al. Adjuvant and salvage radiotherapy after prostatectomy: outcome analysis of 307 patients with prostate cancer. J. Cancer Res. Clin. Oncol. http://dx.doi.org/10.1007/s00432-012-1309-9.

  8. Bolla, M. et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomized controlled trial (EORTC trial 22911). Lancet 380, 2018–2027 (2012).

    Article  Google Scholar 

  9. Parker, C. et al. Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy. BJU Int. 99, 1376–1379 (2007).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Beatrice Detti.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Detti, B., Scartoni, D. Benefit and safety of adjuvant radiation therapy. Nat Rev Urol 10, 131–133 (2013). https://doi.org/10.1038/nrurol.2012.260

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2012.260

  • Springer Nature Limited

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Navigation